1-8 of 8
Luca Boni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P2-11-09: Adding Carboplatin to neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC): a systematic review and meta-analysis

Free
Beatrice Ruffilli, Ida Taglialatela, Francesca D'Avanzo, Valentina Rossi, Benedetta Conte, Francesca Vezzoli, Giorgia Ferrari, Luca Boni, Alessandra Gennari
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P2-11-09.
https://doi.org/10.1158/1557-3265.SABCS24-P2-11-09
Published: 13 June 2025
View articletitled, Abstract P2-11-09: Adding Carboplatin to neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC): a systematic review and meta-analysis
Journal Articles

Abstract P3-12-18: NEOMET: A phase II randomized trial to evaluate the impact of “targeted” nutritional support and exercise on modulation of metabolic and immune-related markers in early breast cancer (eBC) patients candidate to neoadjuvant therapy (NAT)

Free
Ida Taglialatela, Benedetta Conte, Gaia Griguolo, Davide Soldato, Francesca D'Avanzo, Valentina Rossi, Beatrice Ruffilli, Francesca Vezzoli, Alice Coassolo, Fabrizio Condorelli, Erika Del Grosso, Carmelo Bengala, Carmen Branni, Jacopo Gennari, Maria Sole Rossato, Germano Tarantino, Marcello Manfredi, Veronica Martini, Simone Gobbato, Letizia Matera, Nicolo Sala, Luca Boni, Lucia Del Mastro, Valentina Guarneri, Alessandra Gennari
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P3-12-18.
https://doi.org/10.1158/1557-3265.SABCS24-P3-12-18
Published: 13 June 2025
View articletitled, Abstract P3-12-18: NEOMET: A phase II randomized trial to evaluate the impact of “targeted” nutritional support and exercise on modulation of metabolic and immune-related markers in early breast cancer (eBC) patients candidate to neoadjuvant therapy (NAT)
Journal Articles

Abstract GS1-08: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: results from an international cohort study

Free
Matteo Lambertini, Amir Sonnenblick, Elisa Agostinetto, Raphaëlle Bas, Hee Jeong Kim, Maria Alice Franzoi, Rinat Bernstein Molho, Sabine Linn, Ava Kwong, Katarzyna Pogoda, Judith Balmana, Ann Smeets, Jyoti Bajpai, Halle C.F. Moore, Ann H. Partridge, Kelly-Anne Phillips, Angela Toss, Christine Rousset-Jablonski, Fedro A. Peccatori, Tiphaine Renaud, Alberta Ferrari, Shani Paluch-Shimon, Pablo Mando, Jeong Eon Lee, Robert Fruscio, Wanda Cui, Stephanie M. Wong, Claudio Vernieri, Kathryn J. Ruddy, Maria Vittoria Dieci, Alexios Matikas, Mariya Rozenblit, Deniz Can Guven, Minna Lee, Cynthia Villarreal-Garza, Shelley E. Hwang, Laura De Marchis, Fabio Puglisi, Zoe Kemp, Pedro A. Meireles, Anastasia Parokonnaya, Gustavo Werutsky, Maiko Okano, Hatem A. Azim, Jr., Kleida Mati, Shoshana Rosenberg, Richard Gelber, Luca Boni, Eva Blondeaux
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): GS1-08.
https://doi.org/10.1158/1557-3265.SABCS24-GS1-08
Published: 13 June 2025
View articletitled, Abstract GS1-08: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: results from an international cohort study
Journal Articles

Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial

Available to Purchase
Harriet Johansson, Debora Macis, Martino Oliva, Matteo Puntoni, Eva Blondeaux, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Irene Maria Briata, Tania Buttiron-Webber, Luca Boni, Matteo Lazzeroni, Davide Serrano, Livia Giordano, Maria Digennaro, Laura Cortesi, Francesco Millo, Katia Cagossi, Giuseppe Aprile, Fabio Falcini, Elisa Gallerani, Bernardo Bonanni, Andrea DeCensi
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (10): 1841–1846.
https://doi.org/10.1158/1078-0432.CCR-24-2987
Published: 15 May 2025
View articletitled, Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial
Open the PDF for Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial in another window
Includes: Supplementary data
Journal Articles

SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials

Open Access
Benedetta Conte, Luca Boni, Giancarlo Bisagni, Antonio Durando, Giovanni Sanna, Stefania Gori, Ornella Garrone, Stefano Tamberi, Sabino De Placido, Francesco Schettini, Antonio Pazzola, Riccardo Ponzone, Filippo Montemurro, Gianluigi Lunardi, Rosario Notaro, Maria De Angioletti, Anna Turletti, Mauro Mansutti, Fabio Puglisi, Antonio Frassoldati, Mauro Porpiglia, Alessandra Fabi, Daniele Generali, Giovanni Scognamiglio, Maura Rossi, Fara Brasó-Maristany, Aleix Prat, Barbara Cardinali, Patrizia Piccioli, Martina Serra, Sonia Lastraioli, Claudia Bighin, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (24): 5217–5226.
https://doi.org/10.1158/1078-0432.CCR-23-1568
Published: 15 December 2023
View articletitled, SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials
Open the PDF for SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials in another window
Includes: Supplementary data
Journal Articles

Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease

Free
Andrea DeCensi, Matteo Puntoni, Harriet Johansson, Aliana Guerrieri-Gonzaga, Silvia Caviglia, Franca Avino, Laura Cortesi, Antonio Ponti, Maria Grazia Pacquola, Fabio Falcini, Marcella Gulisano, Maria Digennaro, Anna Cariello, Katia Cagossi, Graziella Pinotti, Matteo Lazzeroni, Davide Serrano, Irene Maria Briata, Tania Buttiron Webber, Luca Boni, Bernardo Bonanni
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (13): 3576–3583.
https://doi.org/10.1158/1078-0432.CCR-20-4213
Published: 01 July 2021
View articletitled, Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease
Open the PDF for Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease in another window
Includes: Supplementary data
Journal Articles

hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications

Free
Olivia Crociani, Elena Lastraioli, Luca Boni, Serena Pillozzi, Maria Raffaella Romoli, Massimo D'Amico, Matteo Stefanini, Silvia Crescioli, Antonio Taddei, Lapo Bencini, Marco Bernini, Marco Farsi, Stefania Beghelli, Aldo Scarpa, Luca Messerini, Anna Tomezzoli, Carla Vindigni, Paolo Morgagni, Luca Saragoni, Elisa Giommoni, Silvia Gasperoni, Francesco Di Costanzo, Franco Roviello, Giovanni De Manzoni, Paolo Bechi, Annarosa Arcangeli
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1502–1512.
https://doi.org/10.1158/1078-0432.CCR-13-2633
Published: 13 March 2014
View articletitled, hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications
Open the PDF for hERG1 Channels Regulate VEGF-A Secretion in Human Gastric Cancer: Clinicopathological Correlations and Therapeutical Implications in another window
Includes: Supplementary data
Journal Articles

Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma

Free
Alberto Garaventa, Roberto Luksch, Maria Serena Lo Piccolo, Elena Cavadini, Paolo G. Montaldo, Maria Rosa Pizzitola, Luca Boni, Mirco Ponzoni, Andrea Decensi, Bruno De Bernardi, Franca Fossati Bellani, Franca Formelli
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (6): 2032–2039.
Published: 01 June 2003
View articletitled, Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma
Open the PDF for Phase I Trial and Pharmacokinetics of Fenretinide in Children with Neuroblastoma in another window